7 medtech stories we missed this week: Oct. 13, 2017

[Image from unsplash.com]From Orthocell’s distribution deal to CorNeat unveiling its artificial cornea, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. OrthoCell inks Australian distro deal Orthocell announced in an Oct. 10 press release that it has signed a distribution deal with Surgical Specialities. The deal will make Surgical Specialities the exclusive distributor in Australia and New Zealand for Orthocell’s cell therapies for tendon regeneration and cartilage regeneration. Surgical Specialties is set to take over distribution responsibilities of the Ortho-ATI and Ortho-ACI systems for the next five years. 2. Viveve wins Taiwanese clearance for Viveve system Viveve Medical has won regulatory approval in Taiwan for its Viveve System, according to an Oct. 10 press release. The approval allows the company to market their system in Taiwan for general surgical procedures for electrocoagulation and hemostasis. 3. Faxitron wins FDA nod for radiographic imager Faxitron announced in an Oct. 10 press release that it has won FDA 510(k) clearance for its VersaVision digital imaging system. The imaging system is designed to help create better precision and workflow in clinical settings. It is used for radiographic imaging of core biopsies and surgically excised specimens. 4. Bonesupport launches Cerament trial Bonesupport has entered its first patient into its study for its Cerament G and Cerament V bone substitutes, accordin...
Source: Mass Device - Category: Medical Devices Authors: Tags: 510(k) Business/Financial News Clinical Trials Cosmetic/Aesthetic Food & Drug Administration (FDA) Implants Patient Monitoring Regulatory/Compliance Research & Development Alcon Bonesupport CorNeat Faxitron Masimo MedTech Ort Source Type: news